109 DIVISION OF HEM/ONC: ONCOLOGY BOARD REVIEW CONFERENCE "Early-Stage Lung Cancer (I-III) Part I & Part II" (081822)

Dallas, TX US
August 18, 2022
Course summary
Available credit: 
  • 1.00 AMA
  • 1.00 Attendance
Course opens: 
08/18/2022
Course expires: 
08/18/2022
Event starts: 
08/18/2022 - 7:30am CDT
Event ends: 
08/18/2022 - 8:30am CDT
Cost:
$0.00
Part of: 
109 DIVISION OF HEM/ONC: ONCOLOGY BOARD REVIEW CONFERENCE 2022
Add to calendar: 
UT Southwestern Medical Center
5323 Harry Hines Blvd.
Dallas, TX 75390
United States
Course Director(s)

Amy Jones, M.D.

has no relevant financial relationships to disclose at this time.
Speaker(s)

Jonathan Dowell

has a financial relationship (Professional Services) with Genentech;.
has a financial relationship (Professional Services) with astra zeneca;.
has a financial relationship (Professional Services) with Beigene;.
has a financial relationship (Professional Services) with Janssen;.

Available Credit

  • 1.00 AMA
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.